What Happened?
Waltham, MA-based Regenacy-Pharmaceuticals Appointed Simon Jones as President and Chief Executive Officer
About the Company
Regenacy Pharmaceuticals is developing a novel, disease-modifying approach to treating peripheral neuropathies that goes beyond pain and symptom management to restore peripheral nerve function.
About the Person
Simon Jones is President and Chief Executive Officer at Regenacy Pharmaceuticals. Previously, Simon held various senior HR leadership roles in the industry.
Info Source
News
Short Profile